Aligos Therapeutics
Price & Volume
Stats
See moreOpen | $11.42 |
Previous Close | $11.47 |
Day Range | $10.92-$11.46 |
52W Range | $3.76-$46.80 |
Market Cap | $73.8M |
Shares Short | 226,418 |
Financials
See moreRevenue (12 Mos) | $2.6M |
Revenue Growth (YoY) | -41.6% |
Gross Profit (12 Mos) | -$65.8M |
Diluted EPS | -$13.54 |
News
See moreYahoo Finance • 5 days ago
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
Yahoo Finance • 2 months ago
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
Yahoo Finance • 2 months ago
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
About
CEO | Dr. Lawrence M. Blatt MBA, Ph.D. |
CFO | Ms. Lesley Ann Calhoun CPA |
Address | One Corporate Drive, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
